BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1609692)

  • 1. Evolution of white matter lesions in neurofibromatosis type 1: MR findings.
    Sevick RJ; Barkovich AJ; Edwards MS; Koch T; Berg B; Lempert T
    AJR Am J Roentgenol; 1992 Jul; 159(1):171-5. PubMed ID: 1609692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-neoplastic brain abnormalities on MRI in children and adolescents with neurofibromatosis type 1.
    Raininko R; Thelin L; Eeg-Olofsson O
    Neuropediatrics; 2001 Oct; 32(5):225-30. PubMed ID: 11748492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Encephalic lesions in neurofibromatosis: clinical manifestations and typical magnetic resonance findings].
    Magnaldi S; White RM; Bryan RN
    Radiol Med; 1990 Dec; 80(6):796-807. PubMed ID: 2126389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromatosis type 1 in children: MR imaging and follow-up studies of central nervous system findings.
    Menor F; Marti-Bonmati L; Arana E; Poyatos C; Cortina H
    Eur J Radiol; 1998 Jan; 26(2):121-31. PubMed ID: 9518221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis: hyperintense lesions in the brain on T1-weighted MR images assessed by diffusion tensor imaging.
    Zhou F; Shiroishi M; Gong H; Zee CS
    J Magn Reson Imaging; 2010 Apr; 31(4):789-95. PubMed ID: 20373421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging of myxopapillary ependymoma: findings and value to determine extent of tumor and its relation to intraspinal structures.
    Wippold FJ; Smirniotopoulos JG; Moran CJ; Suojanen JN; Vollmer DG
    AJR Am J Roentgenol; 1995 Nov; 165(5):1263-7. PubMed ID: 7572515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias.
    Della Nave R; Foresti S; Tessa C; Moretti M; Ginestroni A; Gavazzi C; Guerrini L; Salvi F; Piacentini S; Mascalchi M
    Neuroimage; 2004 Jun; 22(2):698-705. PubMed ID: 15193598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole body MR imaging in neurofibromatosis type 1.
    Van Meerbeeck SF; Verstraete KL; Janssens S; Mortier G
    Eur J Radiol; 2009 Feb; 69(2):236-42. PubMed ID: 19091504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis.
    Mirowitz SA; Sartor K; Gado M
    AJR Am J Roentgenol; 1990 Feb; 154(2):369-73. PubMed ID: 2105032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small hyperintense hepatic lesions on T1-weighted images in patients with cirrhosis: evaluation with serial MRI and imaging features for clinical benignity.
    Shimizu A; Ito K; Sasaki K; Hayashida M; Tanabe M; Shimizu K; Matsunaga N
    Magn Reson Imaging; 2007 Dec; 25(10):1430-6. PubMed ID: 17524587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cranial MR imaging in patients with von Recklinghausen's disease (neurofibromatosis type I).
    Hashimoto T; Tayama M; Miyazaki M; Kuroda Y; Hiura K; Hujino K; Yamashita K
    Neuropediatrics; 1990 Nov; 21(4):193-8. PubMed ID: 2127081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content.
    Isiklar I; Leeds NE; Fuller GN; Kumar AJ
    AJR Am J Roentgenol; 1995 Dec; 165(6):1503-12. PubMed ID: 7484597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted MR of the brain: methodology and clinical application.
    Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
    Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging lesion analysis in neurofibromatosis type 1.
    DiMario FJ; Ramsby G
    Arch Neurol; 1998 Apr; 55(4):500-5. PubMed ID: 9561977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type 1.
    Terada H; Barkovich AJ; Edwards MS; Ciricillo SM
    AJNR Am J Neuroradiol; 1996 Apr; 17(4):755-60. PubMed ID: 8730197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
    Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
    AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities.
    Itoh T; Magnaldi S; White RM; Denckla MB; Hofman K; Naidu S; Bryan RN
    AJNR Am J Neuroradiol; 1994 Sep; 15(8):1513-9. PubMed ID: 7985572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging characteristics with pathological correlation of cavernous malformation in cavernous sinus.
    Yao Z; Feng X; Chen X; Zee C
    J Comput Assist Tomogr; 2006; 30(6):975-9. PubMed ID: 17082705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major salivary gland lesions: correlation of MR findings with flow cytometric DNA analysis and prognosis.
    Takashima S; Sone S; Horii A; Okamoto S; Yoshida J
    AJR Am J Roentgenol; 1996 Nov; 167(5):1297-304. PubMed ID: 8911200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation of patients with neurofibromatosis type 1 in infancy and childhood: genetic traits and gender effects.
    Suenobu S; Akiyoshi K; Maeda T; Korematsu S; Izumi T
    J Child Neurol; 2008 Nov; 23(11):1282-7. PubMed ID: 18984837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.